Grace Therapeutics Inc. – Filings and Transcripts

NASDAQ: GRCE
Share price (4/9/26): $3.62
Market cap (4/9/26): $48.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 Q3

ended 09/30/25 Q2 2026 – amended

ended 09/30/25 Q2

ended 06/30/25 Q1

ended 03/31/25 FY 2025

Prospectuses and Registrations Filter

Shelf registration

Exempt offering of securities

Registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

ADAR1 Capital Management, LLC

Nantahala Capital Management, LLC

Kottayil George

News Filter

Announces Third Quarter 2026 Financial Results, Provides Business Update

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Announces Second Quarter 2026 Financial Results, Provides Business Update

Secures Approximately $4.0 Million Through Common Warrant Exercises Following Acceptance of New Drug Application for GTx-104 for Formal FDA Review

Granted Sixth U.S. Patent Covering I.V. Dosing Regimen for GTx-104

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Notice of effectiveness